A pilin from a distinct gut bacterial clade enhances cancer immunotherapy
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Raw data and figure source data of the study.
应用场景：
创建时间：
2024-07-19
相关数据集
prevention of complications from COVID-19 in cancer patients under active treatment
Primary objectives: The aim of the study is to investigate whether supplement of vitamin D may assist in increasing the immunity response to Covid-19 infection, in cancer patients with no or minimal s
NIAID Data Ecosystem40
DAV132 colon-targeted adsorbent prevents antibiotic-related dysbiosis in human volunteers and mitigates anti-PD-1 resistance in murine models
The deleterious impact of antibiotics (ATB) on the microbiome negatively impacts immune checkpoint inhibitor (ICI) response. We assessed the efficacy of DAV132, a colon-targeted adsorbent in 70 health
NIAID Data Ecosystem30
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
To study the impacts of glycolytic states of tumor cells, we took advantage of different in vitro culture systems and established demanded glycolysis states in B16F10 cells. B16F10 cells were maintain
NIAID Data Ecosystem10
Fasting renders immunotherapy effective against low immunogenic breast cancer while reducing side effects
Immunotherapy is having a major impact in the oncology field by improving the prognosis and survival of cancer patients. However, despite positive results for the treatment of different cancers, a maj
NIAID Data Ecosystem40
Mannose enhances anti-PD-1 therapy efficacy in ovarian cancer via modulating gut microbial metabolite.. Mannose enhances anti-PD-1 therapy efficacy in ovarian cancer via modulating gut microbial metabolite.
The gut microbiome serves as a crucial mediator for improving the efficacy of immune checkpoint blockade (ICB) therapy. Here, we show that oral supplementation with prebiotics (mannose) retarded tumor
NIAID Data Ecosystem20
